Clinical Translational Research Center
Boulder, Colorado, 80309, United States
NCT Number: NCT02921659
The purpose of this study is to assess the efficacy of supplementation with the Nicotinamide Adenine Dinucleotide (NAD+) precursor compound, Nicotinamide Riboside (NR), for improving physiological function (vascular, motor, and cognitive) in healthy middle-aged and older adults.
Looking for future studies?
Notify Me55 year–79 year
All sexes
Interventional
Phase 1 / Phase 2
Boulder, Colorado, 80309, United States
Overall, the proposed research project has the long-term potential to influence clinical practice by establishing novel therapies for treating multiple domains of age-associated physiological dysfunction and thereby reducing the risk of clinical disease and disability.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
nicotinamide riboside chloride, 250mg capsules
Other names: Nicotinamide Riboside
silicified microcrystalline cellulose, vegetarian capsule
Time frame: 6 weeks
self reported side effects, vital signs, hematology, liver enzymes, markers of kidney function and blood chemistry
Time frame: 6 weeks
Brachial Artery Flow-Mediated Dilation (FMD)
Time frame: 6 weeks
Aortic Pulse Wave Velocity (PWV)
Time frame: 6 weeks
NIH Toolbox Cognitive Function Battery
Time frame: 6 weeks
NIH Toolbox Motor Function Battery
Time frame: 6 weeks
Assessment of plasma C-reactive protein (CRP) and circulating and mononuclear cell-derived cytokine and antioxidant expression.
University of Colorado, Boulder
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05610059
Aging, Behavior
Tucson, Arizona, United States
View Trial DetailsNCT05017129
Aging
Golden, Colorado, United States
View Trial DetailsNCT03814304
Accidental Falls, Aging
Roslindale, Massachusetts, United States
View Trial DetailsNCT05866393
Aging, Behavior
Cleveland, Ohio, United States
View Trial Details